Impact BioMedical Company Leadership

Impact BioMedical Management Team Effectiveness

The company has Return on Asset of (0.0768) % which means that on every $100 spent on assets, it lost $0.0768. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (3.4699) %, meaning that it generated no profit with money invested by stockholders. Impact BioMedical's management efficiency ratios could be used to measure how well Impact BioMedical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 7th of January 2026, Return On Tangible Assets is likely to drop to -0.78. In addition to that, Return On Capital Employed is likely to drop to 0.04. At this time, Impact BioMedical's Total Current Assets are very stable compared to the past year. As of the 7th of January 2026, Other Current Assets is likely to grow to about 320 K, while Total Assets are likely to drop about 14.2 M. As of the 7th of January 2026, Common Stock Shares Outstanding is likely to grow to about 55.2 M, though Net Loss is likely to grow to (21.1 M). Impact BioMedical has a total of 104.62 Million outstanding shares. Impact BioMedical retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 89.3 (percent) of Impact BioMedical outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Impact BioMedical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Impact BioMedical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Impact BioMedical Workforce Comparison

Impact BioMedical Insider Trading

Impact BioMedical Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Impact BioMedical often depends on how effective the management is. Impact BioMedical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Impact management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Impact management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Impact BioMedical is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical's value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical's market value can be influenced by many factors that don't directly affect Impact BioMedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Impact BioMedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.